Liver cancer cells’ own carbon monoxide powers anticancer drug production in lab tests

Medical Xpress reports that liver cancer cells’ own carbon monoxide powered production of an anticancer drug inside the cells in lab tests, exposing them to its toxic effects. Animal tests are next. A separate post describes a palladium-based catalyst designed to use elevated carbon monoxide in certain cancers to produce a DNA-disrupting compound.